SGLT2 Inhibitors as Systemic Metabolic Modulators: Linking Glucose Excretion to Liver Function Restoration

Sodium-glucose cotransporter 2 (SGLT2) inhibitors have emerged as paradigm-shifting therapeutics that extend beyond glycemic regulation, to conferring profound hepatometabolic benefits. This review delineates the multifaceted mechanisms underlying metabolic dysfunction-associated steatotic liver dis...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Seung Wan Noh, Han Sol Ryu, Yong-Ho Kim, Byung-Chul Oh
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Korean Endocrine Society 2025-12-01
coleção:	Endocrinology and Metabolism
Assuntos:	sodium-glucose transporter 2 inhibitors liver diseases insulin resistance sarcoplasmic reticulum calcium-transporting atpases intracellular calcium homeostasis endoplasmic reticulum stress
Acesso em linha:	http://www.e-enm.org/upload/pdf/enm-2025-2786.pdf
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!